Myclausen

mycophenolate mofetil · Passauer Pharma GmbH

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Myclausen, covering 2026-04-10 to 2026-04-10. Get the full timeline:

Most recent: EMA Authorised: Myclausen (mycophenolate mofetil) — Passauer Pharma GmbH